Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
Clinical guideline published by International Myeloma Foundation (IMF) on
The International Myeloma Foundation (IMF) is dedicated to improving the quality of life for myeloma patients through education, research, and advocacy. They provide resources and support for patients and healthcare professionals, aiming to enhance treatment outcomes and promote awareness of myeloma.